{Reference Type}: Case Reports
{Title}: Toxic optic neuropathy associated with lamotrigine and levetiracetam dual therapy.
{Author}: Chou M;Lai L;Neveu M;Ritchie A;
{Journal}: BMJ Case Rep
{Volume}: 17
{Issue}: 3
{Year}: 2024 Mar 27
暂无{DOI}: 10.1136/bcr-2023-256961
{Abstract}: We report the case of an early adolescent male on lamotrigine and levetiracetam therapy with a 1-month history of progressive, bilateral, painless visual loss which resolved on cessation of lamotrigine. To our knowledge, we present the first case of lamotrigine and levetiracetam dual therapy associated with toxic optic neuropathy, supported by electrophysiology and optical coherence tomography (OCT) changes. Electrophysiology findings were consistent with retinal ganglion cell dysfunction, with bilateral optic nerve involvement. Macula OCT showed mild retinal ganglion cell loss in all inner quadrants bilaterally. This case highlights the importance of asking patients with epilepsy treated with lamotrigine and levetiracetam about visual problems and considering early dose reduction or cessation of treatment.